Background
The Radioisotope Products and Radiation Technology (RPRT) Section of IAEA contributes for production and development of radioisotopes and radiopharmaceuticals. Identifying and addressing the changing needs of the field are necessary for desired outcome of activities of RPRT for the benefit of Member States (MSs).
Aims
[F-18] based molecular probes are vital for clinical applications and used to ascertain the applications of emerging theranostic and therapeutic tracers. The aim of this work is to highlight the efforts of IAEA on the development of radiopharmaceuticals prepared with F-18 and C-11, and associated capacity building, education, and research.
Methods
IAEA mechanisms for supporting MSs are through the implementation of Training Programs, Technical Meetings (TM), Consultancy Meetings (CM), Coordinated Research Projects (CRP), Technical Cooperation (TC) projects mainly for capacity building, manpower training and education, Symposia, Conferences and preparation of Publications and Guidelines.
Results and Conclusion
A CRP on development of F-18 radiopharmaceuticals was implemented (1). The book on facility design and production of F-18-FDG (2) was published. A CM discussed the use of F-18 and C-11 radiopharmaceuticals in neurosciences, the report is in press (3). TC projects on production of F-18 tracers have been implemented.
References
1. Coenen HH et al. Fluorine-18 radiopharmaceuticals beyond [F-18]FDG for use in oncology and neurosciences. Nucl Med. Bio. 2010;37(7):727-74
2. Cyclotron Produced Radionuclides: Guidelines for Setting up a new facility
IAEA Series on “Cyclotron Produced Radionuclides: Guidance on Facility Design and Production of Fluorodeoxyglucose (FDG):  IAEA Technical Series TRS 471
3. Antony D. Gee et al. Radionuclide imaging for neuroscience: Current opinion and future directions.  Molecular Imaging, in press